Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 125 participants.
Also called NCT07757464
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 125 participants
- Sponsor
- Shifa International Hospital
- Registry
-
NCT07757464
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Pakistan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07757464. Randomized; single masking; primary purpose treatment. Start 2026-08-10 (actual); primary completion 2027-01-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes
- Acronym
- PREVENT-SIH
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Hyperglycemia Due to Type 2 Diabetes Mellitus
- Condition
- Osteoarthritis, Knee
- Intervention (Drug)
- Insulin Isophane Human, NPH, Pre-emptive Algorithm
- Intervention (Drug)
- Triamcinolone Acetonide Knee Injection
- Lead sponsor
- Shifa International Hospital
- Collaborator
- Al Ain University
Record details
- Record id
cardio:ct-nct07757464- Content hash
2283d8090c4c3953be43a486ed5c6fd345ed3cafe7013c166a7532caed6b0553